BRK-A vs CI
Berkshire Hathaway Inc. and The Cigna Group, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BRK-A | CI |
|---|---|---|
| Revenue | $247.2B | $274.9B |
| Net income | $67.0B | $6.0B |
| Gross margin | — | 21.8% |
| Net margin | 27.1% | 2.2% |
| Return on equity | 9.8% | 14.4% |
| Diluted EPS | — | $22.18 |
| Dividend / share | — | $6.04 |
| Payout ratio | — | 27.0% |
| Free cash flow | $25.0B | $8.4B |
| Equity | $717.4B | $41.7B |
| Net debt / equity | — | 0.57× |
| Current ratio | — | 0.85× |
| Revenue CAGR 5y | 8.2% | 11.4% |
| Profit CAGR 5y | 9.5% | −6.8% |
BRK-A and CI book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (27.1% against 2.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | BRK-A | CI |
|---|---|---|
| FY2025 | $247.2B | $274.9B |
| FY2024 | $249.7B | $247.1B |
| FY2023 | $254.9B | $195.3B |
| FY2022 | $207.8B | $180.5B |
| FY2021 | $191.3B | $174.1B |
| FY2020 | $166.7B | $160.4B |
| FY2019 | $176.5B | $153.6B |
| FY2018 | $175.4B | $48.6B |
| FY2017 | $239.9B | $41.8B |
| FY2016 | $215.1B | $39.8B |
Net income by year
Bottom line
| Fiscal year | BRK-A | CI |
|---|---|---|
| FY2025 | $67.0B | $6.0B |
| FY2024 | $89.0B | $3.4B |
| FY2023 | $96.2B | $5.2B |
| FY2022 | $-22.8B | $6.8B |
| FY2021 | $89.9B | $5.4B |
| FY2020 | $42.5B | $8.5B |
| FY2019 | $81.4B | $5.1B |
| FY2018 | $4.0B | $2.6B |
| FY2017 | $44.9B | $2.2B |
| FY2016 | $24.1B | $1.8B |
Advertisement
AdSense · Rectangle 336×280